Clinical correlations of mutations in the SCN1A gene:: From febrile seizures to severe myoclonic epilepsy in infancy

被引:109
作者
Ceulemans, BPGM
Claes, LRF
Lagae, LG
机构
[1] Univ Antwerp Hosp, Dept Neurol Child Neurol, UZA, Antwerp, Belgium
[2] Epilepsy Ctr Children & Youth, Pulderbos, Belgium
[3] Univ Hosp Gasthuisberg, Dept Pediat Neurol, B-3000 Louvain, Belgium
[4] Univ Antwerp, Dept Mol Genet, B-2020 Antwerp, Belgium
关键词
D O I
10.1016/j.pediatrneurol.2003.10.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the alpha-subunit of the first neuronal sodium channel gene SCNIA have been described in isolated patients with severe myoclonic epilepsy in infancy or Dravet syndrome and in families with generalized epilepsy with febrile seizures plus. To rind phenotype/genotype correlations, we reviewed all published cases of mutations in SCNIA in addition to four new patients reported here. A total of 60 mutations were observed. Approximately 52% (31/60) are truncating mutations correlating with de novo cases of classical Dravet syndrome in 32 of 34 (94%) patients. Missense mutations in the pore-forming part constitute 27% (16/60) and correspond to a classical type in 12 of 16 (75%) patients. Missense mutations in the voltage sensor were present in 12% (7/60) and correlate with a clinical picture ranging from febrile seizures plus to severe myoclonic epilepsy in infancy. Outside these regions missense mutations are rare and account for only 10% (6/60), corresponding mostly with febrile seizures plus. These results illustrate that the clinical spectrum of SCN1A mutations ranges from febrile seizures, febrile seizures plus, over a milder type to the classical form of severe myoclonic epilepsy in infancy, and confirm the clinical experience that severe myoclonic epilepsy in infancy is the most severe form on this spectrum. (C) 2004 by Elsevier Inc. All rights reserved.
引用
收藏
页码:236 / 243
页数:8
相关论文
共 35 条
[1]   Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation [J].
Abou-Khalil, B ;
Ge, Q ;
Desai, R ;
Ryther, R ;
Bazyk, A ;
Bailey, R ;
Haines, JL ;
Sutcliffe, JS ;
George, AL .
NEUROLOGY, 2001, 57 (12) :2265-2272
[2]   Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man [J].
Alekov, AK ;
Rahman, M ;
Mitrovic, N ;
Lehmann-Horn, F ;
Lerche, H .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2001, 13 (11) :2171-2176
[3]   A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro [J].
Alekov, AK ;
Rahman, MM ;
Mitrovic, N ;
Lehmann-Horn, F ;
Lerche, H .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 529 (03) :533-539
[4]   First genetic evidence of GABAA receptor dysfunction in epilepsy:: a mutation in the γ2-subunit gene [J].
Baulac, S ;
Huberfeld, G ;
Gourfinkel-An, I ;
Mitropoulou, G ;
Beranger, A ;
Prud'homme, JF ;
Baulac, M ;
Brice, A ;
Bruzzone, R ;
LeGuern, E .
NATURE GENETICS, 2001, 28 (01) :46-48
[5]   A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33 [J].
Baulac, S ;
Gourfinkel-An, I ;
Picard, F ;
Rosenberg-Bourgin, M ;
Prud'homme, JF ;
Baulac, M ;
Brice, A ;
LeGuern, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) :1078-1085
[6]   Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial [J].
Chiron, C ;
Marchand, MC ;
Tran, A ;
Rey, E ;
d'Athis, P ;
Vincent, J ;
Dulac, O ;
Pons, G .
LANCET, 2000, 356 (9242) :1638-1642
[7]   De Novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy [J].
Claes, L ;
Ceulemans, B ;
Audenaert, D ;
Smets, K ;
Löfgren, A ;
Del-Favero, J ;
Ala-Mello, S ;
Basel-Vanagaite, L ;
Plecko, B ;
Raskin, S ;
Thiry, P ;
Wolf, NI ;
Van Broeckhoven, C ;
De Jonghe, P .
HUMAN MUTATION, 2003, 21 (06) :615-621
[8]   De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy [J].
Claes, L ;
Del-Favero, J ;
Ceulemans, B ;
Lagae, L ;
Van Broeckhoven, C ;
De Jonghe, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1327-1332
[9]   Topiramate as add-on drug in severe myoclonic epilepsy in infancy:: an Italian multicenter open trial [J].
Coppola, G ;
Capovilla, G ;
Montagnini, A ;
Romeo, A ;
Spanò, M ;
Tortorella, G ;
Veggiotti, P ;
Viri, M ;
Pascotto, A .
EPILEPSY RESEARCH, 2002, 49 (01) :45-48
[10]   Severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures [J].
Doose, H ;
Lunau, H ;
Castiglione, E ;
Waltz, S .
NEUROPEDIATRICS, 1998, 29 (05) :229-238